Snowball logo
logo
ALGS_logo

Aligos Therapeutics Inc

ALGS NASDAQ
$5.05+$0.06  (1.2%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4.35913.9115.533.9452.18631.52
COGS
104.23.6753.0692.6220.93-
Gross Profit
4.35913.9115.533.9451.25631.26
Operating Expenses & Income
Operating Income
(128.3)(97.58)(88.13)(89.15)(87.98)(78.99)
Total Operating Expenses
132.7111.5103.793.189.24110.3
R&D Expenses
104.285.0873.0470.2769.4588.38
Selling General & Admin Expenses
28.5326.4130.6222.8320.7222.14
Earnings from Continuing Operations
Interest Expense
(0.132)(1.64)----
Interest Income
0.1321.641.243--0.764
Income Tax Expense
0.1430.1060.7950.3310.3143.214
Net Income
Net Income
(128.3)(96.05)(87.68)(131.2)(24.19)(75.96)
Supplemental
EBIT
(128.3)(97.58)(86.88)(130.9)(23.88)(72.75)
EBITDA
(124.5)(93.91)(83.81)(128.3)(22.95)(71.19)
In millions of USD, except % and values per 1 share